SCHEMBL2345447

SCHEMBL2345447

COC(=O)c1ccc(NC=O)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.60
NPC1 O15118 4/20 0.57
RAB9A P51151 4/20 0.57
HSP90AA1 P07900 1/20 0.57
MEN1 O00255 4/20 0.56
KMT2A Q03164 4/20 0.56
CA1 P00915 2/20 0.55
CA2 P00918 2/20 0.55
TDP1 Q9NUW8 1/20 0.55
CA12 O43570 1/20 0.55
CA7 P43166 1/20 0.55
CA9 Q16790 1/20 0.55
CA14 Q9ULX7 1/20 0.55
MAPT P10636 5/20 0.53
TSHR P16473 1/20 0.52
KDM4E B2RXH2 2/20 0.51
HPGD P15428 2/20 0.51
MAPK1 P28482 1/20 0.51
HTT P42858 1/20 0.51
SMN1; SMN2 Q16637 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7337412 0.84 NPC1 (0.57) ALDH1A1NPC1RAB9AHSP90AA1MEN1
SCHEMBL27516651 0.82 NPC1 (0.55) ALDH1A1NPC1RAB9AHSP90AA1MEN1
SCHEMBL27307708 0.82 NPC1 (0.55) ALDH1A1NPC1RAB9AHSP90AA1MEN1
SCHEMBL6288070 0.82 CA12 (0.46) ALDH1A1NPC1RAB9AHSP90AA1MEN1
SCHEMBL4746034 0.82 RAB9A (0.62) ALDH1A1NPC1RAB9AMEN1KMT2A
SCHEMBL28753388 0.80 CA1 (0.73) ALDH1A1NPC1RAB9AMEN1KMT2A
SCHEMBL28993944 0.80 CA1 (0.80) ALDH1A1NPC1RAB9AMEN1KMT2A
SCHEMBL14470122 0.80 KDM4E (0.50) ALDH1A1MEN1KMT2ACA1CA2
SCHEMBL23600 0.80 CA1 (0.80) ALDH1A1NPC1RAB9AMEN1KMT2A
SCHEMBL24339221 0.79 RAB9A (0.53) ALDH1A1NPC1RAB9AHSP90AA1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250011330-A1 Imidazo[1,2- a]pyrazine and Imidazo[1,2- a]pyridine Based Tyrosyl-DNA Phosphodiesterase I (TDP1) Inhibitors LEIDOS BIOMEDICAL RESEARCH INC. 2025-01-09 US disclosed
EP-4284798-A1 IMIDAZO[1,2-A]PYRAZINE AND IMIDAZO[1,2-A]PYRIDINE BASED TYROSYL-DNA PHOSPHODIESTERASE I (TDP1) INHIBITORS The USA, as represented by The Secretary, Department of Health and Human Services (US) 2023-12-06 EP disclosed
WO-2022164934-A1 IMIDAZO[1,2-A]PYRAZINE AND IMIDAZO[1,2-A]PYRIDINE BASED TYROSYL-DNA PHOSPHODIESTERASE I (TDP1) INHIBITORS THE USA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (US) 2022-08-04 WO disclosed
EP-2978751-B1 TETRAHYDROISOQUINOLINES CONTAINING SUBSTITUTED AZOLES AS FACTOR XIA INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-12-05 EP disclosed
US-9862675-B1 Method of N-formylating amines with a phosphonic anhydride KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2018-01-09 US disclosed
US-9738655-B2 Tetrahydroisoquinolines containing substituted azoles as factor XIa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2017-08-22 US disclosed
US-20160145263-A1 TETRAHYDROISOQUINOLINES CONTAINING SUBSTITUTED AZOLES AS FACTOR XIA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2016-05-26 US disclosed
EP-2978751-A1 TETRAHYDROISOQUINOLINES CONTAINING SUBSTITUTED AZOLES AS FACTOR XIA INHIBITORS Bristol-Myers Squibb Company (US) 2016-02-03 EP disclosed
WO-2014160668-A1 TETRAHYDROISOQUINOLINES CONTAINING SUBSTITUTED AZOLES AS FACTOR XIA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2014-10-02 WO disclosed
EP-2570418-A2 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-03-20 EP disclosed
US-5344933-A Pyrrole ring-or condensed pyrrole ring-containing azomethine dye FUJI PHOTO FILM CO., LTD. (JP) 1994-09-06 US disclosed
US-5262377-A Colorfastness FUJI PHOTO FILM CO., LTD. (JP) 1993-11-16 US disclosed
US-5238903-A Azo-methine dye on support FUJI PHOTO FILM CO., LTD. (JP) 1993-08-24 US disclosed
US-5227359-A Pyrazoloazole dyes FUJI PHOTO FILM CO., LTD. (JP) 1993-07-13 US disclosed
EP-0540854-A2 Preparation for promoting hair growth Sansho Seiyaku Co., Ltd. (JP) 1993-05-12 EP disclosed
US-5210200-A Fast to heat and light FUJI PHOTO FILM CO., LTD. (JP) 1993-05-11 US disclosed
EP-0518238-A1 Pyrrolotriazole derivative FUJI PHOTO FILM CO., LTD. (JP) 1992-12-16 EP disclosed
US-5128312-A Thermal transfer dye donating material FUJI PHOTO FILM CO., LTD. (JP) 1992-07-07 US disclosed
EP-0423796-A1 Thermal transfer dye donating materials FUJI PHOTO FILM CO., LTD. (JP) 1991-04-24 EP disclosed
US-4975409-A Ketone imine dyes; colorfastness; copies FUJI PHOTO FILM CO., LTD. (JP) 1990-12-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250011330-A1 Imidazo[1,2- a]pyrazine and Imidazo[1,2- a]pyridine Based Tyrosyl-DNA Phosphodiesterase I (TDP1) Inhibitors TDP1, TDP2, TOP1 ALDH1A1 769/4885NPC1 3699/4885RAB9A 4179/4885
US-20160145263-A1 TETRAHYDROISOQUINOLINES CONTAINING SUBSTITUTED AZOLES AS FACTOR XIA INHIBITORS TFPI2, TFPI, F12 ALDH1A1 3928/4885NPC1 3095/4885RAB9A 3375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.